Which combination drug contains both a steroid and a LABA?

The combination drug that contains both a steroid and a long-acting beta-agonist (LABA) is Fluticasone and Salmeterol, commonly known by the brand name Advair. This medication combines an inhaled corticosteroid, Fluticasone, which reduces inflammation in the airways, and Salmeterol, a LABA that helps to relax and open the airways to improve breathing.

Using this combination is beneficial for asthma management as it targets both the underlying inflammation and provides longer-lasting relief from bronchoconstriction, making it effective for individuals with moderate to severe persistent asthma. This dual action allows for better control of asthma symptoms and reduces the risk of exacerbations, enhancing the overall quality of life for individuals with asthma.

The other options do not represent a steroid-LABA combination. For instance, Cromolyn Sodium and Nedocromil Sodium are both mast cell stabilizers but do not have steroid or LABA properties. Formoterol and Epinephrine is not a standard combination for continued asthma management, as Epinephrine is a rescue medication and not used in combination therapy like LABAs. Budesonide and Montelukast also do not fit the criteria; Budesonide is a steroid,